Shareholding for the Period Ended September 30, 2018
Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here18-10-2018
18-10-2018
Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- VINOD GOELDesignation :- Company Secretary and Compliance Officer17-10-2018
Certificate Pursuant To Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Half-Year Ended 30Th September, 2018
Pursuant to the provisions of Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certified copy of certificate from M/s. R & D, Company Secretaries, for the half-year ended 30th September, 2018, confirming that all the transfers of shares have been completed within the stipulated time. This is for your kind information and record please. Kindly acknowledge the receipt.12-10-2018
Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 For The Half-Year Ended On 30Th September, 2018
Pursuant to the provisions of Regulation 7(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certificate duly signed by Skyline Financial Services Pvt. Ltd., Share Transfer Agent and Company Secretary of Panacea Biotec Ltd. for the half year ended on 30th September, 2018 in compliance of Regulation 7(2) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015....10-10-2018
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Panacea Biotec Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here01-10-2018
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
In continuation of our earlier letter dated September 29, 2018 informing that the detailed results of remote e-voting and the poll conducted at the Annual General Meeting ('AGM') of the Company held on September 29, 2018, as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations') shall be forwarded to you on the receipt of Scrutinizer's Report....01-10-2018
Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to the provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), please find enclosed herewith the proceedings of the 34th Annual General Meeting of the Company held on September 29, 2018, at the registered office of the Company at Ambala-Chandigarh Highway, Lalru - 140501, Punjab....30-09-2018
Compliance Under Regulation 47 Of SEBI (Listing Obligations And Disclosure Requirements), 2015
Dear Sir/Madam Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), 2015, please find enclosed herewith copies of the newspaper advertisements regarding Notice of AGM, Remote E-voting Information and Book Closure published in the following newspapers on September 06, 2018:- Business Standard, English Edition Desh Sewak, Punjabi Edition This is for your kind information and record please.07-09-2018
Intimation Of The 34Th Annual General Meeting Of Company For The Financial Year 2017-18 And Details Of Book Closure, Cut-Off Date For E-Voting And E-Voting Period
We would like to inform you that the 34th Annual General Meeting ('AGM') of the Company is scheduled to be held on Saturday, September 29, 2018 at 11:30 A.M. at the Registered Office of the Company at Ambala-Chandigarh Highway, Lalru - 140501, Punjab. A copy of the Notice of AGM is attached herewith for your reference. Further, pursuant to the provisions of Section 108 of the Act read with Rule 20 of the Companies (Management and Administration)...05-09-2018
Panacea inks deal with Natco, Breckenridge
Panacea Biotec on Monday inked a tripartite pact with Natco Pharma and Breckenridge Pharmaceutical Inc to manufacture and supply Azacitidine injection27-08-2018